source
- Compass Pathways leads race for first psychedelic drug approval, non-profit rivalsCompass Pathways is widely viewed as a leading candidate to bring the first psychedelic medicine to market. The company has advanced its therapy through clinical development and is positioned near…
- Advanced analytics enable up to 12% cut in control animal use while keeping study rigorThe control group is a cornerstone of nonclinical safety studies, providing the baseline needed to separate a drug’s effects from normal biological variation. Researchers are now applying virtual…